An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

Local Institution - 0027, Liège

Local Institution - 0017, La Louvière

Local Institution - 0018, Ghent

Local Institution - 0028, Ghent

Local Institution - 0016, Sint-Niklaas

Local Institution - 0038, The Bronx

Local Institution - 0023, Bergamo

Local Institution - 0029, Madrid

Local Institution - 0030, Madrid

Local Institution - 0007, Greenville

Local Institution - 0009, Atlanta

Local Institution - 0005, Jacksonville

Local Institution - 0004, Nashville

Local Institution - 0032, Seville

Local Institution - 0026, Parma

Local Institution - 0002, Cleveland

Local Institution - 0008, Cleveland

Local Institution - 0015, Essen

Local Institution - 0003, St Louis

Local Institution - 0034, Strasbourg

Local Institution - 0033, Pierre-Bénite

Local Institution - 0012, Stuttgart

Local Institution - 0006, Springdale

Local Institution - 0013, Löwenstein

Local Institution - 0036, Paris

Local Institution - 0039, Toulon

Local Institution - 0014, Immenstadt im Allgäu

Local Institution - 0025, Catania

Local Institution - 0010, Craiova

Local Institution - 0011, Cluj-Napoca

Local Institution - 0001, New Haven

Local Institution - 0024, Perugia

Local Institution - 0021, Amsterdam

Local Institution - 0022, Nijmegen

Local Institution - 0031, Barcelona